Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.

Hedenus M, Karlsson T, Ludwig H, et al.
Med Oncol 2014;31:302.
NATA Rating :
Review by : M. Auerbach
NATA Review

This study supports and corroborates the role of intravenous iron in preventing significant anaemia progression as well as providing a clinical benefit without the use of the much more expensive erythropoiesis-stimulating agents.

Extremely well done and worth reading.

– Michael Auerbach

Discuss this article on the Nataonline forum

Consent Management Platform by Real Cookie Banner